This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chertova, E.
Right arrow Articles by Ott, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chertova, E.
Right arrow Articles by Ott, D. E.

 Previous Article  |  Next Article 

Journal of Virology, September 2006, p. 9039-9052, Vol. 80, No. 18
0022-538X/06/$08.00+0     doi:10.1128/JVI.01013-06

Proteomic and Biochemical Analysis of Purified Human Immunodeficiency Virus Type 1 Produced from Infected Monocyte-Derived Macrophages

Elena Chertova,1* Oleg Chertov,2 Lori V. Coren,1 James D. Roser,1 Charles M. Trubey,1 Julian W. Bess Jr.,1 Raymond C. Sowder II,1 Eugene Barsov,1 Brian L. Hood,2 Robert J. Fisher,2 Kunio Nagashima,2 Thomas P. Conrads,2 Timothy D. Veenstra,2 Jeffrey D. Lifson,1 and David E. Ott1

AIDS Vaccine Program, Basic Research Program,1 Research Technology Program, SAIC—Frederick, Inc., NCI—Frederick, Frederick, Maryland 217022

Received 17 May 2006/ Accepted 24 June 2006

Human immunodeficiency virus type 1 (HIV-1) infects CD4+ T lymphocytes and monocytes/macrophages, incorporating host proteins in the process of assembly and budding. Analysis of the host cell proteins incorporated into virions can provide insights into viral biology. We characterized proteins in highly purified HIV-1 virions produced from human monocyte-derived macrophages (MDM), within which virus buds predominantly into intracytoplasmic vesicles, in contrast to the plasmalemmal budding of HIV-1 typically seen with infected T cells. Liquid chromatography-linked tandem mass spectrometry of highly purified virions identified many cellular proteins, including 33 previously described proteins in HIV-1 preparations from other cell types. Proteins involved in many different cellular structures and functions were present, including those from the cytoskeleton, adhesion, signaling, intracellular trafficking, chaperone, metabolic, ubiquitin/proteasomal, and immune response systems. We also identified annexins, annexin-binding proteins, Rab proteins, and other proteins involved in membrane organization, vesicular trafficking, and late endosomal function, as well as apolipoprotein E, which participates in cholesterol transport, immunoregulation, and modulation of cell growth and differentiation. Several tetraspanins, markers of the late endosomal compartment, were also identified. MDM-derived HIV contained 26 of 37 proteins previously found in exosomes, consistent with the idea that HIV uses the late endosome/multivesicular body pathway during virion budding from macrophages.


* Corresponding author. Mailing address: AIDS Vaccine Research Program, SAIC—Frederick, Inc., NCI—Frederick, Frederick, MD 21702. Phone: (301) 846-1455. Fax: (301) 846-5588. E-mail: chertova{at}ncifcrf.gov.


Journal of Virology, September 2006, p. 9039-9052, Vol. 80, No. 18
0022-538X/06/$08.00+0     doi:10.1128/JVI.01013-06




This article has been cited by other articles:

  • Henriet, S., Mercenne, G., Bernacchi, S., Paillart, J.-C., Marquet, R. (2009). Tumultuous Relationship between the Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) and the Human APOBEC-3G and APOBEC-3F Restriction Factors. Microbiol. Mol. Biol. Rev. 73: 211-232 [Abstract] [Full Text]  
  • Joshi, A., Ablan, S. D., Soheilian, F., Nagashima, K., Freed, E. O. (2009). Evidence that Productive Human Immunodeficiency Virus Type 1 Assembly Can Occur in an Intracellular Compartment. J. Virol. 83: 5375-5387 [Abstract] [Full Text]  
  • Graner, M. W., Alzate, O., Dechkovskaia, A. M., Keene, J. D., Sampson, J. H., Mitchell, D. A., Bigner, D. D. (2009). Proteomic and immunologic analyses of brain tumor exosomes. FASEB J. 23: 1541-1557 [Abstract] [Full Text]  
  • Khatua, A. K., Taylor, H. E., Hildreth, J. E. K., Popik, W. (2009). Exosomes Packaging APOBEC3G Confer Human Immunodeficiency Virus Resistance to Recipient Cells. J. Virol. 83: 512-521 [Abstract] [Full Text]  
  • Thomas, J. A., Bosche, W. J., Shatzer, T. L., Johnson, D. G., Gorelick, R. J. (2008). Mutations in Human Immunodeficiency Virus Type 1 Nucleocapsid Protein Zinc Fingers Cause Premature Reverse Transcription. J. Virol. 82: 9318-9328 [Abstract] [Full Text]  
  • LeBouder, F., Morello, E., Rimmelzwaan, G. F., Bosse, F., Pechoux, C., Delmas, B., Riteau, B. (2008). Annexin II Incorporated into Influenza Virus Particles Supports Virus Replication by Converting Plasminogen into Plasmin. J. Virol. 82: 6820-6828 [Abstract] [Full Text]  
  • Burt, T. D., Agan, B. K., Marconi, V. C., He, W., Kulkarni, H., Mold, J. E., Cavrois, M., Huang, Y., Mahley, R. W., Dolan, M. J., McCune, J. M., Ahuja, S. K. (2008). Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE {varepsilon}4/{varepsilon}4 genotype accelerates HIV disease progression. Proc. Natl. Acad. Sci. USA 105: 8718-8723 [Abstract] [Full Text]  
  • Kuciak, M., Gabus, C., Ivanyi-Nagy, R., Semrad, K., Storchak, R., Chaloin, O., Muller, S., Mely, Y., Darlix, J.-L. (2008). The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro. Nucleic Acids Res 36: 3389-3400 [Abstract] [Full Text]  
  • Ruiz-Mateos, E., Pelchen-Matthews, A., Deneka, M., Marsh, M. (2008). CD63 Is Not Required for Production of Infectious Human Immunodeficiency Virus Type 1 in Human Macrophages. J. Virol. 82: 4751-4761 [Abstract] [Full Text]  
  • Ringrose, J. H., Jeeninga, R. E., Berkhout, B., Speijer, D. (2008). Proteomic Studies Reveal Coordinated Changes in T-Cell Expression Patterns upon Infection with Human Immunodeficiency Virus Type 1. J. Virol. 82: 4320-4330 [Abstract] [Full Text]  
  • Segura, M. M., Garnier, A., Di Falco, M. R., Whissell, G., Meneses-Acosta, A., Arcand, N., Kamen, A. (2008). Identification of Host Proteins Associated with Retroviral Vector Particles by Proteomic Analysis of Highly Purified Vector Preparations. J. Virol. 82: 1107-1117 [Abstract] [Full Text]  
  • Gaskill, P. J., Zandonatti, M., Gilmartin, T., Head, S. R., Fox, H. S. (2008). Macrophage-Derived Simian Immunodeficiency Virus Exhibits Enhanced Infectivity by Comparison with T-Cell-Derived Virus. J. Virol. 82: 1615-1621 [Abstract] [Full Text]  
  • Sato, K., Aoki, J., Misawa, N., Daikoku, E., Sano, K., Tanaka, Y., Koyanagi, Y. (2008). Modulation of Human Immunodeficiency Virus Type 1 Infectivity through Incorporation of Tetraspanin Proteins. J. Virol. 82: 1021-1033 [Abstract] [Full Text]  
  • Alvarez, R., Reading, J., King, D. F. L., Hayes, M., Easterbrook, P., Farzaneh, F., Ressler, S., Yang, F., Rowley, D., Vyakarnam, A. (2008). WFDC1/ps20 Is a Novel Innate Immunomodulatory Signature Protein of Human Immunodeficiency Virus (HIV)-Permissive CD4+ CD45RO+ Memory T Cells That Promotes Infection by Upregulating CD54 Integrin Expression and Is Elevated in HIV Type 1 Infection. J. Virol. 82: 471-486 [Abstract] [Full Text]  
  • Maxwell, K. L., Frappier, L. (2007). Viral Proteomics. Microbiol. Mol. Biol. Rev. 71: 398-411 [Abstract] [Full Text]  
  • Waheed, A. A., Ablan, S. D., Roser, J. D., Sowder, R. C., Schaffner, C. P., Chertova, E., Freed, E. O. (2007). HIV-1 escape from the entry-inhibiting effects of a cholesterol-binding compound via cleavage of gp41 by the viral protease. Proc. Natl. Acad. Sci. USA 104: 8467-8471 [Abstract] [Full Text]  
  • Kadiu, I., Ricardo-Dukelow, M., Ciborowski, P., Gendelman, H. E. (2007). Cytoskeletal Protein Transformation in HIV-1-Infected Macrophage Giant Cells. J. Immunol. 178: 6404-6415 [Abstract] [Full Text]